Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiogenesis Inhibition in Oncology”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Early research (Phase 1)Study completedNCT00019565
What this trial is testing

PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 53
Large-scale testing (Phase 3)Study completedNCT03042611
What this trial is testing

Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer

Who this might be right for
Gastric CancerGastric Adenocarcinoma
Elevar Therapeutics 460
Testing effectiveness (Phase 2)Study completedNCT00094835
What this trial is testing

Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-Small Cell Lung Cancer
Amgen 51
Testing effectiveness (Phase 2)Looking for participantsNCT06878625
What this trial is testing

A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer

Who this might be right for
Evaluating the Efficacy of Trop-2 ADC Combination Therapy in Advanced Triple-Negative Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 138
Early research (Phase 1)Study completedNCT00033215
What this trial is testing

S-3304 in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Shionogi 32
Early research (Phase 1)Study completedNCT00654758
What this trial is testing

A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
AbbVie 33
Testing effectiveness (Phase 2)Study completedNCT00083707
What this trial is testing

Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
University of Arkansas 40
Early research (Phase 1)Study completedNCT01468922
What this trial is testing

Pazopanib and ARQ 197 for Advanced Solid Tumors

Who this might be right for
Solid Tumor
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Study completedNCT00094107
What this trial is testing

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

Who this might be right for
MelanomaSkin Neoplasms
Pfizer 32
Early research (Phase 1)Study completedNCT00403221
What this trial is testing

Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Baylor College of Medicine 19
Testing effectiveness (Phase 2)WithdrawnNCT00244920
What this trial is testing

Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute
Early research (Phase 1)Study completedNCT00093873
What this trial is testing

Study Evaluating AMG 706 in Subjects With Advanced Solid Tumors

Who this might be right for
Tumors
Amgen 71
Testing effectiveness (Phase 2)Study completedNCT00176774
What this trial is testing

Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma

Who this might be right for
Colorectal Carcinoma
University of Michigan Rogel Cancer Center 24
Testing effectiveness (Phase 2)UnknownNCT03461185
What this trial is testing

Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Xinqiao Hospital of Chongqing 100
Early research (Phase 1)Study completedNCT01260025
What this trial is testing

Tolerability and Pharmacokinetics of M2ES in the Treatment of Advanced Solid Tumor

Who this might be right for
TolerabilityPharmacokineticsEndostatin
Sun Yat-sen University 20
Early research (Phase 1)Study completedNCT00129337
What this trial is testing

Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Tumors
Peregrine Pharmaceuticals 28
Testing effectiveness (Phase 2)Looking for participantsNCT04069273
What this trial is testing

Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Who this might be right for
Gastric CancerGastroEsophageal CancerAdenocarcinoma
Harry H Yoon 58
Testing effectiveness (Phase 2)Study completedNCT01391962
What this trial is testing

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Who this might be right for
Sarcoma, Alveolar Soft Part
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT01006369
What this trial is testing

Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Rutgers, The State University of New Jersey 38
Testing effectiveness (Phase 2)Study completedNCT00108069
What this trial is testing

Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

Who this might be right for
Glioma
National Cancer Institute (NCI) 43
Load More Results